Cargando…
Translational reprogramming as a driver of antimony-drug resistance in Leishmania
Leishmania is a unicellular protozoan that has a limited transcriptional control and mostly uses post-transcriptional regulation of gene expression, although the molecular mechanisms of the process are still poorly understood. Treatments of leishmaniasis, pathologies associated with Leishmania infec...
Autores principales: | Gutierrez Guarnizo, Sneider Alexander, Tikhonova, Elena B., Karamyshev, Andrey L., Muskus, Carlos E., Karamysheva, Zemfira N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163012/ https://www.ncbi.nlm.nih.gov/pubmed/37147291 http://dx.doi.org/10.1038/s41467-023-38221-1 |
Ejemplares similares
-
Metabolite Biomarkers of Leishmania Antimony Resistance
por: Gutierrez Guarnizo, Sneider Alexander, et al.
Publicado: (2021) -
Regulation of Translation in the Protozoan Parasite Leishmania
por: Karamysheva, Zemfira N., et al.
Publicado: (2020) -
Drug-Induced Lipid Remodeling in Leishmania Parasites
por: Gutierrez Guarnizo, Sneider Alexander, et al.
Publicado: (2021) -
Pathogenic signal peptide variants in the human genome
por: Gutierrez Guarnizo, Sneider Alexander, et al.
Publicado: (2023) -
Translational Control of Secretory Proteins in Health and Disease
por: Karamyshev, Andrey L., et al.
Publicado: (2020)